{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:10:41Z","timestamp":1778937041263,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ahj.2026.107439","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:45:06Z","timestamp":1775259906000},"page":"107439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Economic burden associated with systemic inflammation in patients with HFmrEF\/HFpEF"],"prefix":"10.1016","volume":"298","author":[{"given":"Taiwo P.","family":"Adesoba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Skaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Goss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5169-117X","authenticated-orcid":false,"given":"Josephine","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2026.107439_bib0001","first-page":"e41","article-title":"2025 Heart Disease and Stroke Statistics: a report of US and global data from the American Heart Association","volume":"151","author":"Martin","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107439_bib0002","doi-asserted-by":"crossref","first-page":"oeab001","DOI":"10.1093\/ehjopen\/oeab001","article-title":"Causes of hospitalization in the USA between 2005 and 2018","volume":"1","author":"Salah","year":"2021","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.ahj.2026.107439_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007763","article-title":"Estimated health care utilization and expenditures in individuals with heart failure from the medical expenditure panel survey","volume":"14","author":"Klein","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2026.107439_bib0004","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jchf.2022.05.006","article-title":"Expenditure on heart failure in the United States: the Medical Expenditure Panel Survey 2009-2018","volume":"10","author":"Bhatnagar","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ahj.2026.107439_bib0005","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107439_bib0006","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107439_bib0007","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107439_bib0008","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","article-title":"SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2026.107439_bib0009","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107439_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.medici.2015.12.001","article-title":"Clinical relevance of high sensitivity C-reactive protein in cardiology","volume":"52","author":"Adukauskiene","year":"2016","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ahj.2026.107439_bib0011","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","article-title":"Chronic heart failure and inflammation: what do we really know?","volume":"119","author":"Dick","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2026.107439_bib0012","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jacc.2023.05.035","article-title":"C-reactive protein and risk of incident heart failure in patients with cardiovascular disease","volume":"82","author":"Burger","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107439_bib0013","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2023.05.036","article-title":"The evolving role of C-reactive protein in heart failure: implications for patients with cardiovascular disease","volume":"82","author":"Jialal","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107439_bib0014","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jchf.2023.06.031","article-title":"Interleukin-6 in patients with heart failure and preserved ejection fraction","volume":"11","author":"Alogna","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ahj.2026.107439_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010051","article-title":"Adverse outcomes associated with interleukin-6 in patients recently hospitalized for heart failure with preserved ejection fraction","volume":"16","author":"Mooney","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2026.107439_bib0016","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ejhf.1482","article-title":"The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study","volume":"21","author":"Markousis-Mavrogenis","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2026.107439_bib0017","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cardfail.2023.10.399","article-title":"Prevalence and clinical significance of systemic inflammation In Hfpef and Hfmref","volume":"30","author":"Borlaug","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2026.107439_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004700","article-title":"Development and preliminary validation of a Medicare claims-based model to predict left ventricular ejection fraction class in patients with heart failure","volume":"11","author":"Desai","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2026.107439_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252903","article-title":"External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure","volume":"16","author":"Mahesri","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2026.107439_bib0020","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ahj.2026.107439_bib0021","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0167-6296(98)00032-0","article-title":"Modeling risk using generalized linear models","volume":"18","author":"Blough","year":"1999","journal-title":"J Health Econ"},{"key":"10.1016\/j.ahj.2026.107439_bib0022","series-title":"Consumer price index for all urban consumers: medical care in U.S. city average [CPIMEDNS], retrieved from FRED","year":"2025"},{"key":"10.1016\/j.ahj.2026.107439_bib0023","series-title":"R: a language and environment for statistical computing","year":"2025"},{"issue":"suppl_1","key":"10.1016\/j.ahj.2026.107439_bib0024","article-title":"Healthcare resource utilisation and cost of care of systemic inflammation in individuals with atherosclerotic cardiovascular disease and chronic kidney disease","volume":"45","author":"Rudolfsen","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107439_bib0025","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1093\/eurheartj\/ehae557","article-title":"Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease","volume":"45","author":"Mazhar","year":"2024","journal-title":"Eur Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326001018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326001018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:45:53Z","timestamp":1778935553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870326001018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":25,"alternative-id":["S0002870326001018"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107439","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic burden associated with systemic inflammation in patients with HFmrEF\/HFpEF","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107439"}}